Closing in on a new treatment for sleeping sickness.
Publication
, Journal Article
Derbyshire, ER; Clardy, J
Published in: eLife
July 2013
A chemoproteomics approach has been employed to identify a kinase that could be used as a druggable target in efforts to develop new treatments for African sleeping sickness.
Duke Scholars
Published In
eLife
DOI
EISSN
2050-084X
ISSN
2050-084X
Publication Date
July 2013
Volume
2
Start / End Page
e01042
Related Subject Headings
- Zearalenone
- Trypanosoma brucei brucei
- Fungi
- Antiprotozoal Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Derbyshire, E. R., & Clardy, J. (2013). Closing in on a new treatment for sleeping sickness. ELife, 2, e01042. https://doi.org/10.7554/elife.01042
Derbyshire, Emily R., and Jon Clardy. “Closing in on a new treatment for sleeping sickness.” ELife 2 (July 2013): e01042. https://doi.org/10.7554/elife.01042.
Derbyshire ER, Clardy J. Closing in on a new treatment for sleeping sickness. eLife. 2013 Jul;2:e01042.
Derbyshire, Emily R., and Jon Clardy. “Closing in on a new treatment for sleeping sickness.” ELife, vol. 2, July 2013, p. e01042. Epmc, doi:10.7554/elife.01042.
Derbyshire ER, Clardy J. Closing in on a new treatment for sleeping sickness. eLife. 2013 Jul;2:e01042.
Published In
eLife
DOI
EISSN
2050-084X
ISSN
2050-084X
Publication Date
July 2013
Volume
2
Start / End Page
e01042
Related Subject Headings
- Zearalenone
- Trypanosoma brucei brucei
- Fungi
- Antiprotozoal Agents
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 0601 Biochemistry and Cell Biology